VestGen Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$519K Sell
8,887
-4,564
-34% -$254K 0.02% 596
2026
Q2
$732K Sell
13,451
-6,923
-34% -$337K 0.02% 544
2026
Q1
$1.01M Buy
+20,374
New +$876K 0.03% 464
2025
Q4
– Sell
-8,500
Closed -$351K – 789
2025
Q3
$351K Hold
8,500
– – 0.01% 563
2025
Q2
$375K Hold
8,500
– – 0.01% 463
2025
Q1
$314K Buy
+8,500
New +$303K 0.01% 454

Other funds holding EXEL

VestGen Advisors's EXEL Position: Q3 2026 in Review

VestGen Advisors reduced its Exelixis (EXEL) stake by 34% in Q3 2026, selling an estimated $254K and leaving 8,887 shares worth $519K. The position accounts for 0.02% of the portfolio, ranked #596.

VestGen Advisors first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.01M in Q1 2026. 775 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • VestGen Advisors held 8,887 shares of Exelixis worth $519K as of Q3 2026.
  • VestGen Advisors sold 4,564 Exelixis shares in Q3 2026, an estimated $254K.
  • Exelixis made up 0.02% of VestGen Advisors's portfolio in Q3 2026, its #596 holding.
  • VestGen Advisors first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Exelixis position peaked at $1.01M in Q1 2026.
  • 775 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on VestGen Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.